Long Focus Capital Management’s Aura Biosciences AURA Stock Holding History

Long Focus Capital Management’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.9M	Hold	4,619,582	–	–	0.81%	35
2025 Q4	$25.2M	Hold	4,619,582	–	–	0.66%	41
2025 Q3	$28.5M	Hold	4,619,582	–	–	0.94%	30
2025 Q2	$28.9M	Buy	4,619,582 +1,300,000	+39%	+$7.6M	1.09%	25
2025 Q1	$19.5M	Buy	3,319,582 +781,808	+31%	+$5.91M	0.65%	38
2024 Q4	$20.9M	Buy	2,537,774 +1,404,228	+124%	+$13.2M	0.68%	28
2024 Q3	$10.1M	Buy	1,133,546 +76,358	+7%	+$655K	0.35%	44
2024 Q2	$7.99M	Buy	1,057,188 +561,766	+113%	+$4.11M	0.31%	48
2024 Q1	$3.89M	Buy	495,422 +155,000	+46%	+$1.28M	0.2%	65
2023 Q4	$3.02M	Buy	340,422 +145,247	+74%	+$1.23M	0.1%	71
2023 Q3	$1.75M	Buy	195,175 +15,000	+8%	+$161K	0.06%	73
2023 Q2	$2.23M	Buy	180,175 +8,798	+5%	+$94K	0.1%	67
2023 Q1	$1.59M	Buy	+171,377	New	+$1.78M	0.09%	77

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Long Focus Capital Management's AURA Position: Q1 2026 in Review

Long Focus Capital Management held its Aura Biosciences (AURA) position steady in Q1 2026 at 4,619,582 shares worth $30.9M. The position accounts for 0.81% of the portfolio, ranked #35.

Long Focus Capital Management first reported a position in AURA in Q1 2023 and has held it in 13 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

Long Focus Capital Management held 4,619,582 shares of Aura Biosciences worth $30.9M as of Q1 2026.
Long Focus Capital Management left its Aura Biosciences share count unchanged in Q1 2026.
Aura Biosciences made up 0.81% of Long Focus Capital Management's portfolio in Q1 2026, its #35 holding.
Long Focus Capital Management first reported a position in Aura Biosciences in Q1 2023 and has held it in 13 quarters since.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Long Focus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.